Revenue: The sum of all revenue fields included for a company's operating activities.
NovaBay Pharmaceuticals, Inc. (NBY) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$7.67M |
|
-- |
|
-- |
|
$3.29M |
|
$-3.29M |
|
$-0.04M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$7.67M |
|
$-3.33M |
|
$-3.29M |
|
$-3.29M |
|
5.31M |
|
5.42M |
|
$1.44 |
|
$1.42 |
|
| Balance Sheet Financials | |
$9.04M |
|
$0.01M |
|
$0.83M |
|
$9.87M |
|
$3.07M |
|
-- |
|
$0.64M |
|
$3.71M |
|
$6.16M |
|
$6.17M |
|
$6.17M |
|
5.82M |
|
| Cash Flow Statement Financials | |
$-1.32M |
|
-- |
|
$-1.71M |
|
$0.91M |
|
$8.94M |
|
$8.04M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.05% |
|
-54.00% |
|
-33.73% |
|
-54.00% |
|
$1.06 |
|
$-0.24 |
|
$-0.24 |
|